ERK signaling mediates long-term low concentration 3,3′-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: An in vitro and in vivo study

被引:9
|
作者
Li, Fen [1 ]
Chen, Chen [1 ]
Chen, Shi-Ming [1 ,2 ]
Xiao, Bo-Kui [1 ]
Tao, Ze-Zhang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Otolaryngol Head & Neck Surg Res Inst, Wuhan 430060, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg 2, Wuhan 430060, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; tumor prevention; lymph node metastasis; long-term intake; low concentration; 3,3 '-diindolylmethane; ERK; CANCER CELLS; APOPTOSIS; PROLIFERATION; INDOLE-3-CARBINOL; BREAST;
D O I
10.3892/or.2015.4428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well known that crucifers have antitumor effects and 3,3'-diindolylmethane (DIM) is one of the major bioactive components; and the associated molecular mechanisms in a short-term high-dose manner are widely discussed. However, the antitumor effects of DIM in a long-term low-dose manner in nasopharyngeal carcinoma (NPC) has not been reported yet, as to the potential mechanisms in the human body. In the present study, NPC cells were induced by 20 mu mol/l DIM for over a month, and the proliferation, apoptosis, migration and in vivo metastasis were investigated. The results showed that DIM significantly reduced the proliferation and migration; however, changes in apoptosis were not observed. In vivo study showed the metastasis was significantly reduced. Compared to the short-term high-dose manner, incomplete similar qualities were observed; next we explored the possible signal pathway revolved, the ERK signaling showed similar changes, while the PI3K/Akt, NF-kappa B, P38, JNK pathways were significantly altered in the short-term high-dose manner (our previous study) showed no obvious change, indicating the ERK signaling may be the main effector of DIM.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 6 条
  • [1] In vivo and in vitro study on the role of 3,3-diindolylmethane in treatment and prevention of nasopharyngeal carcinoma
    Chen, Chen
    Chen, Shi-Ming
    Xu, Bin
    Chen, Zhe
    Wang, Fei
    Ren, Jie
    Xu, Yong
    Wang, Yan
    Xiao, Bo-Kui
    Tao, Ze-Zhang
    CARCINOGENESIS, 2013, 34 (08) : 1815 - 1821
  • [2] 3,3′-Diindolylmethane inhibits the invasion and metastasis of nasopharyngeal carcinoma cells in vitro and in vivo by regulation of epithelial mesenchymal transition
    Wu, Tingting
    Chen, Chen
    Li, Fen
    Chen, Zhe
    Xu, Yong
    Xiao, Botui
    Tao, Zezhang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (06) : 1635 - 1638
  • [3] PI3K/AKT1 Signaling Pathway Mediates Sinomenine-Induced Hepatocellular Carcinoma Cells Apoptosis: An in Vitro and in Vivo Study
    Luo, Yan
    Liu, Liwei
    Zhao, Jihua
    Jiao, Yue
    Zhang, Meiyu
    Xu, Guangli
    Jiang, Yumao
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (05) : 614 - 624
  • [4] Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up
    Kure, Shoko
    Chiba, Tomohiro
    Ebina, Aya
    Toda, Kazuhisa
    Jikuzono, Tomoo
    Motoda, Norio
    Mitani, Hiroki
    Sugitani, Iwao
    Takeuchi, Kengo
    Ohashi, Ryuji
    ENDOCRINE JOURNAL, 2022, 69 (03) : 273 - 281
  • [5] Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the stemness of human bone marrow mesenchymal stem cells (hBMSCs) during long-term expansion by preserving mitochondrial function via the PI3K/AKT, ERK1/2, and STAT3 signaling pathways
    Cao, Zeyuan
    Xie, Yunyi
    Yu, Le
    Li, Yi
    Wang, Yan
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [6] Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the stemness of human bone marrow mesenchymal stem cells (hBMSCs) during long-term expansion by preserving mitochondrial function via the PI3K/AKT, ERK1/2, and STAT3 signaling pathways
    Zeyuan Cao
    Yunyi Xie
    Le Yu
    Yi Li
    Yan Wang
    Stem Cell Research & Therapy, 11